Catalyst Funds Management Pty Ltd Invests $547,000 in Healthpeak Properties, Inc. $DOC

Catalyst Funds Management Pty Ltd purchased a new stake in Healthpeak Properties, Inc. (NYSE:DOC) in the 4th quarter, Holdings Channel reports. The fund purchased 34,000 shares of the real estate investment trust’s stock, valued at approximately $547,000.

Other institutional investors have also recently modified their holdings of the company. WPG Advisers LLC grew its holdings in Healthpeak Properties by 270.2% during the fourth quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock worth $26,000 after acquiring an additional 1,197 shares during the period. Elyxium Wealth LLC acquired a new stake in Healthpeak Properties in the fourth quarter valued at $31,000. CYBER HORNET ETFs LLC acquired a new stake in Healthpeak Properties in the second quarter valued at $33,000. Wiser Advisor Group LLC purchased a new stake in shares of Healthpeak Properties during the 3rd quarter worth $38,000. Finally, AlphaQuest LLC boosted its position in shares of Healthpeak Properties by 49.2% during the 3rd quarter. AlphaQuest LLC now owns 2,864 shares of the real estate investment trust’s stock worth $55,000 after purchasing an additional 944 shares in the last quarter. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the company’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total value of $213,736.05. Following the sale, the insider owned 7,636 shares of the company’s stock, valued at $148,520.20. This represents a 59.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.23% of the stock is owned by company insiders.

Healthpeak Properties Trading Up 0.0%

Shares of DOC stock opened at $19.74 on Monday. The stock has a market cap of $13.61 billion, a P/E ratio of 61.68, a P/E/G ratio of 2.51 and a beta of 1.00. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15. Healthpeak Properties, Inc. has a fifty-two week low of $15.70 and a fifty-two week high of $19.91. The business has a fifty day simple moving average of $17.49 and a 200-day simple moving average of $17.26.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, topping the consensus estimate of $0.43 by $0.02. The business had revenue of $752.95 million for the quarter, compared to analyst estimates of $694.59 million. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The business’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. On average, analysts forecast that Healthpeak Properties, Inc. will post 1.75 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Friday, June 26th. Shareholders of record on Monday, June 15th will be given a dividend of $0.1017 per share. The ex-dividend date is Monday, June 15th. This represents a c) dividend on an annualized basis and a yield of 6.2%. Healthpeak Properties’s payout ratio is presently 381.25%.

Wall Street Analyst Weigh In

DOC has been the subject of a number of research analyst reports. Citigroup increased their price target on shares of Healthpeak Properties from $17.50 to $20.00 and gave the company a “neutral” rating in a report on Tuesday, May 12th. Wall Street Zen raised shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a report on Sunday, May 10th. Morgan Stanley upped their target price on shares of Healthpeak Properties from $18.00 to $20.00 and gave the stock an “overweight” rating in a research report on Friday. Wells Fargo & Company reaffirmed a “positive” rating on shares of Healthpeak Properties in a report on Tuesday, February 3rd. Finally, Robert W. Baird lifted their price target on shares of Healthpeak Properties from $19.00 to $21.00 and gave the company an “outperform” rating in a research report on Wednesday, May 13th. Five equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $19.08.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.